anonymous
Guest
anonymous
Guest
Pharmaceutical company Eli Lilly (LLY) reported first-quarter 2020 revenue of $5.86 billion, up 15% year-over-year.
Amid COVID-19 pandemic, the company saw increased customer buying patterns and prescription trends which resulted in a revenue increase of approx. $250 million for the quarter.
The company has adjusted its earnings guidance for the full year 2020.
The graphical representation of the earnings results can be found here.
Amid COVID-19 pandemic, the company saw increased customer buying patterns and prescription trends which resulted in a revenue increase of approx. $250 million for the quarter.
The company has adjusted its earnings guidance for the full year 2020.
The graphical representation of the earnings results can be found here.